Wednesday, July 8, 2026

pharma · Rheumatoid Arthritis · Calcium

Universal Integrated

Universal Corporation is a pharma organization headquartered in HILLSIDE, NJ, CN. Primary therapeutic focus areas include Rheumatoid Arthritis, Calcium, Polycystic Ovary Syndrome, Diabetic Foot, Plaque Psoriasis. NovaPha

HILLSIDE, NJ, CN HQ
2006 Founded
304 Employees
NMPA registrant Type
Company details
Status
Public
HQ
HILLSIDE, NJ, CN
Founded
2006
Employees
304
Programs
89
Drugs
105
Patents
42
Clinical program

Oxaliplatin

Phase 2 · small molecule · Previously Treated Metastatic Non-Small Cell Lung Cancer

Oxaliplatin for Previously Treated Metastatic Non-Small Cell Lung Cancer is a Phase 2 program (small_molecule) at Universal Integrated with 1 ClinicalTrials.gov record(s).

← All Universal Integrated projects Phase 2 small molecule active

Internal code OX-03-087

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Universal Integrated
Phase
Phase 2
Modality
small_molecule
Indication
Previously Treated Metastatic Non-Small Cell Lung Cancer
Status
active
Trials
1